000 | 00949 a2200277 4500 | ||
---|---|---|---|
005 | 20250511145714.0 | ||
264 | 0 | _c19790126 | |
008 | 197901s 0 0 eng d | ||
022 | _a0362-6350 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarker, L A | |
245 | 0 | 0 |
_aPlatelet survival time: its measurement and use. _h[electronic resource] |
260 |
_bProgress in hemostasis and thrombosis _c1978 |
||
300 |
_a321-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aArteriosclerosis _xblood |
650 | 0 | 4 |
_aBlood Platelets _xcytology |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDipyridamole _xpharmacology |
650 | 0 | 4 |
_aHeparin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSerotonin _xmetabolism |
650 | 0 | 4 |
_aThrombosis _xblood |
773 | 0 |
_tProgress in hemostasis and thrombosis _gvol. 4 _gp. 321-47 |
|
999 |
_c735570 _d735570 |